Skye Bioscience, Inc. (SKYE)
2.03
-0.14
(-6.45%)
USD |
NASDAQ |
Aug 25, 16:00
2.03
0.00 (0.00%)
After-Hours: 18:54
Skye Bioscience Shareholders Equity (Quarterly) : -0.4973M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4973M |
| March 31, 2026 | 9.012M |
| December 31, 2025 | 20.02M |
| September 30, 2025 | 32.84M |
| June 30, 2025 | 43.68M |
| March 31, 2025 | 59.25M |
| December 31, 2024 | 68.15M |
| September 30, 2024 | 75.80M |
| June 30, 2024 | 72.81M |
| March 31, 2024 | 78.88M |
| December 31, 2023 | -2.132M |
| September 30, 2023 | 1.695M |
| June 30, 2023 | -7.789M |
| March 31, 2023 | -4.781M |
| December 31, 2022 | -3.008M |
| September 30, 2022 | -3.285M |
| June 30, 2022 | -0.3018M |
| March 31, 2022 | 2.973M |
| December 31, 2021 | 5.864M |
| September 30, 2021 | 8.265M |
| June 30, 2021 | 2.271M |
| March 31, 2021 | 2.479M |
| December 31, 2020 | 0.4508M |
| September 30, 2020 | 1.853M |
| June 30, 2020 | -3.094M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.703M |
| December 31, 2019 | 0.5481M |
| September 30, 2019 | -16.40M |
| June 30, 2019 | -11.64M |
| March 31, 2019 | -27.86M |
| December 31, 2018 | -15.56M |
| September 30, 2018 | -10.16M |
| June 30, 2018 | -8.245M |
| March 31, 2018 | -5.754M |
| December 31, 2017 | -0.8001M |
| September 30, 2017 | -2.105M |
| June 30, 2017 | -1.778M |
| March 31, 2017 | -1.229M |
| December 31, 2016 | -1.451M |
| September 30, 2016 | -1.019M |
| June 30, 2016 | -0.2555M |
| March 31, 2016 | -1.010M |
| December 31, 2015 | 0.471M |
| September 30, 2015 | 1.026M |
| June 30, 2015 | -0.861M |
| March 31, 2015 | -0.3384M |
| December 31, 2014 | -0.4535M |
| September 30, 2014 | 0.7763M |
| April 30, 2014 | 0.0734M |
| January 31, 2014 | 0.087M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| Viking Therapeutics, Inc. | 408.32M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.03M |
| Total Liabilities (Quarterly) | 11.53M |
| Debt to Equity Ratio | -0.3593 |
| Current Ratio | 0.9504 |
| Net Debt Paydown Yield | 0.19% |